Financials VITA 34 AG

Equities

V3V

DE000A0BL849

Healthcare Facilities & Services

Market Closed - Xetra 11:36:10 2024-04-26 am EDT 5-day change 1st Jan Change
5.15 EUR +6.40% Intraday chart for VITA 34 AG +15.99% -1.72%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 44.52 52.07 51.43 239.8 123.8 89.77 89.77 -
Enterprise Value (EV) 1 45.24 50.25 46.34 239 135.7 101.8 96.37 91.17
P/E ratio 54.5 x 38.6 x 33.9 x -23.8 x -4.57 x -21.5 x -42.9 x -57.2 x
Yield 1.47% 1.25% - - - - - -
Capitalization / Revenue 2.18 x 2.57 x 2.56 x 8.44 x 1.8 x 1.17 x 1.13 x 1.1 x
EV / Revenue 2.22 x 2.48 x 2.31 x 8.41 x 1.97 x 1.33 x 1.22 x 1.12 x
EV / EBITDA 9.58 x 8.75 x 7.99 x 294 x -38.1 x 25.4 x 16.3 x 13.2 x
EV / FCF 12 x 10.2 x 13.9 x 512 x -12.4 x -29.1 x 17.5 x 17.9 x
FCF Yield 8.37% 9.79% 7.2% 0.2% -8.05% -3.44% 5.71% 5.59%
Price to Book 1.51 x 1.73 x 1.74 x 2.03 x 7.5 x - - -
Nbr of stocks (in thousands) 4,084 4,084 4,098 15,989 15,828 17,432 17,432 -
Reference price 2 10.90 12.75 12.55 15.00 7.820 5.150 5.150 5.150
Announcement Date 3/28/19 3/23/20 3/30/21 4/30/22 4/30/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 20.41 20.25 20.07 28.42 68.94 76.8 79.1 81.5
EBITDA 1 4.722 5.746 5.8 0.814 -3.564 4 5.9 6.9
EBIT 1 2.631 3.282 2.88 -3.071 -27.28 -3.7 -2 -1.1
Operating Margin 12.89% 16.21% 14.35% -10.81% -39.57% -4.82% -2.53% -1.35%
Earnings before Tax (EBT) 1 1.784 3.142 2.27 -3.447 -28.29 -5.8 -3 -2.1
Net income 1 0.828 1.35 1.151 -3.667 -27.09 -4.2 -2.2 -1.5
Net margin 4.06% 6.67% 5.74% -12.9% -39.29% -5.47% -2.78% -1.84%
EPS 2 0.2000 0.3300 0.3700 -0.6300 -1.710 -0.2400 -0.1200 -0.0900
Free Cash Flow 1 3.786 4.918 3.335 0.467 -10.92 -3.5 5.5 5.1
FCF margin 18.55% 24.29% 16.62% 1.64% -15.84% -4.56% 6.95% 6.26%
FCF Conversion (EBITDA) 80.18% 85.59% 57.5% 57.37% - - 93.22% 73.91%
FCF Conversion (Net income) 457.25% 364.3% 289.75% - - - - -
Dividend per Share 0.1600 0.1600 - - - - - -
Announcement Date 3/28/19 3/23/20 3/30/21 4/30/22 4/30/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2022 Q1 2022 Q2 2022 S1
Net sales 1 9.768 - 16.63 32.11
EBITDA 1 2.789 - -1.549 -2.613
EBIT - - - -
Operating Margin - - - -
Earnings before Tax (EBT) - - - -
Net income - -2.81 - -
Net margin - - - -
EPS - -0.1800 - -
Dividend per Share - - - -
Announcement Date 8/29/19 5/31/22 8/30/22 8/30/22
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 0.73 - - - 11.9 12 6.6 1.4
Net Cash position 1 - 1.82 5.09 0.86 - - - -
Leverage (Debt/EBITDA) 0.1542 x - - - -3.339 x 3 x 1.119 x 0.2029 x
Free Cash Flow 1 3.79 4.92 3.34 0.47 -10.9 -3.5 5.5 5.1
ROE (net income / shareholders' equity) 2.81% 4.53% 4% -10.6% -90.9% -25.5% -12% -9.4%
ROA (Net income/ Total Assets) 1.37% 2.24% 1.96% -3.1% -16.4% -2.8% -1.4% -1%
Assets 1 60.56 60.21 58.62 118.3 164.7 150 157.1 150
Book Value Per Share 7.200 7.360 7.210 7.400 1.040 - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.81 1.4 0.65 2.26 6.43 3.8 2 2.5
Capex / Sales 3.98% 6.91% 3.21% 7.95% 9.33% 4.95% 2.53% 3.07%
Announcement Date 3/28/19 3/23/20 3/30/21 4/30/22 4/30/23 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.15 EUR
Average target price
5.3 EUR
Spread / Average Target
+2.91%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. V3V Stock
  4. Financials VITA 34 AG